ProfileGDS5678 / 1421295_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 13% 13% 15% 12% 31% 17% 12% 13% 13% 13% 12% 13% 15% 13% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.357713
GSM967853U87-EV human glioblastoma xenograft - Control 22.3237813
GSM967854U87-EV human glioblastoma xenograft - Control 32.3667915
GSM967855U87-EV human glioblastoma xenograft - Control 42.2629412
GSM967856U87-EV human glioblastoma xenograft - Control 52.6666231
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4739817
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.3232412
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.3008213
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2950413
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.3129613
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.298712
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2977913
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.3590315
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.315113